On October 21, China Merchants CSI Vaccine and Biotechnology ETF (561920) closed up 0.00%, with a turnover of 558,400 yuan.
Vaccine Leading ETF (561920) was established on March 15, 2023, and the full name of the fund is China Merchants CSI Vaccine and Biotechnology Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as China Merchants CSI Vaccine and Biotechnology ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the leading vaccine ETF (561920) is based on the return rate of the CSI Vaccine and Biotechnology Index.
In terms of scale, as of October 18, the latest share of the vaccine leading ETF (561920) was 28.692 million shares, and the latest scale was 19.6942 million yuan. Looking back on December 29, 2023, the share of the vaccine leading ETF (561920) was 35.692 million shares, with a scale of 31.6088 million yuan. That is, the share of the fund has decreased by 19.61% and the scale has decreased by 37.69% since the beginning of this year.
In terms of liquidity, as of October 21, the cumulative turnover of the vaccine leading ETF (561920) in the past 20 trading days was 10.6383 million yuan, with an average daily turnover of 531,900 yuan, and since the beginning of this year, the cumulative turnover has been 148 million yuan in 191 trading days, with an average daily turnover of 777,500 yuan.
The
current fund manager of the vaccine leading ETF (561920) is Hou Hao. Hou Hao has managed (or intends to manage) the fund since July 13, 2024, with a return of 14.80% during his tenure.
According to the latest regular report, the heavy stocks of the leading vaccine ETF (561920) include Zhifei Biotech, Wantai Biotech, Watson Biotech, Hualan Biotech, Kangtai Biotech, Junshi Biotech, Shandong Yaobo, Gan & Lee Pharmaceutical, BeiGene, and Fosun Pharma, with the following proportions.
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 300122 | Zhifei Biotech | 11.42%, | 90,302,530,400 | |
| 603392 | Wantai Biotech | 8.69%, | 29,201,925,000 | |
| 300142 | Watson Biotech | 6.32% | 123,001,400,000 | |
| 002007 | Hualan Biotech | 6.00% | 84,11,328,100 | |
| 300601 | Kangtai Biotech | 3.62%, | 51,408,190,688,180||
| Junshi Biosciences | 3.28%, | 25,00726,000 | ||
| 600529 | Shandong Pharmaceutical Glass | 3.17%, | 27,701,900 | |
| 603087 | Gan & Lee Pharmaceutical | 3.16%, | 15,1069,400 | |
| 688235 | BeiGene | 3.08% | 5894.00 | 682,800 |
| 600196 | Fosun Pharma | 2.99% | 29,9062,000 |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date
